Article
Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Oct 2018
Regalado Ellen S, Mellor-Crummey Lauren, De Backer Julie, Braverman Alan C, Ades Lesley, Benedict Susan, Bradley Timothy J, Brickner M Elizabeth, Chatfield Kathryn C, Child Anne, Feist Cori, Holmes Kathryn W, Iannucci Glen, Lorenz Birgit, Mark Paul, Morisaki Takayuki, Morisaki Hiroko, Morris Shaine A, Mitchell Anna L, Ostergaard John R, Richer Julie, Sallee Denver, Shalhub Sherene, Tekin Mustafa, Estrera Anthony, Musolino Patricia, Yetman Anji, Pyeritz Reed, Milewicz Dianna M
Abstract excerpt
PURPOSE: Smooth muscle dysfunction syndrome (SMDS) due to heterozygous ACTA2 arginine 179 alterations is characterized by patent ductus arteriosus, vasculopathy (aneurysm and occlusive lesions), pulmonary arterial hypertension, and other complications in smooth muscle-dependent organs. We sought to define the clinical history of SMDS to develop recommendations for evaluation and management. METHODS: Medical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
